FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

758 letters match. Newest first.

  1. Sky Bank Media, LLC dba Painless Tattoo Cream Co.

    FDA warned Painless Tattoo Cream Co. that its numbing cream and spray are unapproved new drugs with excess lidocaine.

    High risk
  2. Tattoo Numbing Cream Co.

    Tattoo Numbing Cream Co. sold Signature Tattoo Numbing Cream and Miracle Numb Spray as unapproved drugs for tattooing.

    High risk
  3. Dermal Source, Inc.

    FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.

    High risk
  4. TKTX Company

    TKTX Company sells unapproved, misbranded lidocaine numbing creams online at illegal concentrations for cosmetic procedures.

    High risk
  5. Indelicare DBA INKEEZE

    FDA warns Indelicare that its INKEEZE lidocaine numbing gel, spray and foam soap are unapproved new drugs sold outside OTC limits.

    High risk
  6. Higley Industries, Inc.

    FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.

    High risk
  7. Medline Industries, LP

    FDA warns Medline over uncleared syringes in surgical kits and unresolved design and complaint failures.

    High risk
  8. Human Microbes

    FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.

    High risk
  9. Nobles Medical Technology II, Inc.

    FDA warns Nobles Medical Technology II over oversight failures in NobleStitch EL clinical study.

    High risk
  10. Cosmetic Specialty Labs, Inc.

    FDA warned Cosmetic Specialty Labs after an inspection found manufacturing failures in OTC drugs and an unlisted product.

    High risk
  11. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  12. Amman Pharmaceutical Industries

    FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.

    High risk
  13. Pt Dua Kelinci

    FDA found Pt Dua Kelinci made ready-to-eat snacks under insanitary conditions, with dirty equipment and allergen cross-contact risks.

    High risk
  14. Madhu Instruments Private Limited

    FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.

    High risk
  15. Iowa Egg Company Inc.

    Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.

    High risk
  16. Indian Groceries and Spices, Inc.

    FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.

    Medium
  17. S & J International Enterprises Public Company Limited

    FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.

    High risk
  18. Marion Mullet Farm

    FDA warned Indiana calf dealer Marion Mullet Farm about medicated calves sold without treatment records or withdrawal compliance.

    High risk
  19. Martin Farm, Konrad Martin

    Nappanee dairy farm used enrofloxacin and ceftiofur in calves contrary to labeling and kept incomplete treatment records.

    High risk
  20. Glicerinas Industriales, S.A. de C.V.

    FDA warned Glicerinas Industriales over CGMP failures in repackaged glycerin and propylene glycol, including DEG/EG testing and particulate contamination.

    High risk
  21. Comercializadora Internacional Piscicola New Your S.A

    Colombian tilapia processor's HACCP plan omits Clostridium botulinum and drug-residue hazards, FDA says after remote assessment.

    High risk
  22. Samuel Rodriguez dba KiloKennelzz

    KiloKennelzz marketed Green Monster, an unapproved injectable animal drug, online with claims to treat dog diseases.

    High risk
  23. Prime Lab LLC

    Prime Lab LLC failed U.S. drug manufacturing quality rules for over-the-counter hand soaps and sanitizers, including raw-material testing and shared toxic equipment.

    High risk
  24. MiMedx Group, Inc.

    FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.

    High risk
  25. Hua Da Trading, Inc.

    FDA warned Hua Da Trading over WeFun, an unapproved drug sold as a supplement that contains undeclared sildenafil.

    High risk
  26. Patcos Cosmetics Pvt. Ltd.

    Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.

    High risk
  27. Anish S. Shah, M.D./Siyan Clinical Research

    FDA warned clinical investigator Dr. Anish Shah that he broke blinding rules in a depression drug study, calling the site's data into question.

    Medium
  28. Sudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi

    FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.

    High risk
  29. Terragene S.A.

    Terragene S.A. made sterilization indicator devices with complaint-handling and MDR failures and uncleared extended-cycle claims.

    High risk
  30. Desserts by Helen, Inc.

    FDA cited Desserts by Helen for unsanitary conditions and cleaning failures at its Louisville ready-to-eat bakery.

    High risk
  31. Fresenius Medical Care AG & Co. KGaA

    FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.

    High risk
  32. American Aquarium Products

    American Aquarium Products sells unapproved, misbranded antimicrobial drugs for aquarium fish, FDA says.

    High risk
  33. Aquanest Biotic

    FDA warned Aquanest Biotic over selling unapproved, misbranded antimicrobial drugs for aquarium fish and birds.

    High risk
  34. Aquarium Pharmacy LLC

    Aquarium Pharmacy sold unapproved antibiotics for aquarium fish without required FDA approval or listing.

    High risk
  35. California Veterinary Supply

    California Veterinary Supply marketed unapproved aquarium antibiotics containing medically important antimicrobials, FDA says.

    High risk
  36. Chewy, Inc.

    FDA warns Chewy over unapproved, misbranded medically important antibiotics for fish and birds.

    High risk
  37. Silver Lease, LLC

    Silver Lease marketed unapproved Fishbiotic antimicrobials for aquarium fish without required FDA approval or drug listing.

    High risk
  38. Kraft Drug

    Kraft Drug marketed unapproved antibiotics for aquarium fish and birds as over-the-counter drugs, FDA says.

    High risk
  39. Midland Vet Services

    Midland Vet Services marketed unapproved antimicrobial drugs for aquarium fish and birds without FDA approval or drug listing.

    High risk
  40. Valley Vet Supply

    FDA warned Valley Vet Supply over unapproved, misbranded fish and bird antibiotics sold on its website.

    High risk
  41. Novid Group, Inc.

    FDA told Novid Group its OTC nasal spray, novid NASAL SPRAY, is an unapproved new drug and misbranded.

    High risk
  42. Nutra Blend, LLC subsidiary of Land O’Lakes

    Nutra Blend's medicated calf feed contained unintended monensin, killing calves and prompting a recall.

    High risk
  43. Intas Pharmaceuticals Limited

    FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.

    High risk
  44. AmLion Toothpaste Mfg. Sdn. Bhd.

    FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.

    High risk
  45. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk
  46. Cerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi

    FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.

    High risk
  47. Brenntag Great Lakes, LLC

    Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.

    High risk
  48. Wello Inc.

    FDA cited Wello Inc. for misbranded welloStationX devices because labels lacked unique device identifiers and required GUDID data were not submitted.

    Low
  49. Independent Seafoods Panama, S.A. dba Panama Artisanal Seafoods FQ

    FDA warned Independent Seafoods Panama over missing written seafood safety plans for fresh and histamine fish.

    High risk
  50. PESCAMOZ LDA

    FDA says PESCAMOZ lacked required seafood safety plans for tuna and swordfish, calling products adulterated.

    High risk